omeprazole has been researched along with Esophageal Diseases in 45 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
Excerpt | Relevance | Reference |
---|---|---|
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 7.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
"Oesophageal candidiasis was diagnosed incidentally at endoscopy in two patients receiving omeprazole therapy." | 7.68 | Oesophageal candidiasis after omeprazole therapy. ( Larner, AJ; Lendrum, R, 1992) |
"Such chronic ulcers have been associated with pain, stricture formation, and recurrent hemorrhage." | 5.28 | Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. ( Gimson, A; Polson, R; Westaby, D; Williams, R, 1990) |
" Adverse events that occurred significantly more often in the first month of treatment with esomeprazole compared with months 2-6 included diarrhoea, nausea/vomiting, abdominal pain, dyspepsia, headache/migraine, intolerance, malaise/lassitude, pruritus, unspecified adverse effects and abnormal sensation." | 3.74 | Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England. ( Davies, M; Shakir, SA; Wilton, LV, 2008) |
"Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 3.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
"Septicemia occurred in a long-term hemodialysis patient on oral iron supplementation who had been treated for esophageal ulcer by omeprazole, an ulcer-healing drug." | 3.68 | Septicemia due to Yersinia enterocolitica in a hemodialyzed, iron-depleted patient receiving omeprazole and oral iron supplementation. ( Fakir, M; Hardin, JM; Matta, B; Saison, C; Wong, T, 1992) |
"Oesophageal candidiasis was diagnosed incidentally at endoscopy in two patients receiving omeprazole therapy." | 3.68 | Oesophageal candidiasis after omeprazole therapy. ( Larner, AJ; Lendrum, R, 1992) |
"There were no recurrences of Schatzki's ring in the group of patients with documented GERD (follow-up [mean +/- SD]: 43." | 2.71 | Long-term acid suppressive therapy may prevent the relapse of lower esophageal (Schatzki's) rings: a prospective, randomized, placebo-controlled study. ( Avgerinos, A; Bergele, C; Karamanolis, G; Mantides, A; Papadopoulou, E; Sgouros, SN; Stefanidis, G; Vassiliadis, K; Vlachogiannakos, J, 2005) |
"Lansoprazole has undergone extensive clinical evaluation for the treatment of acid-peptic diseases." | 2.40 | Safety profile of Lansoprazole: the US clinical trial experience. ( Freston, JW; Haber, M; Heller, CA; Jennings, D; Rose, PA, 1999) |
"Severe gastroesophageal reflux disease is usually a chronic problem with periods of relapse, but effective medical and surgical therapies are available." | 2.39 | Severe gastroesophageal reflux disease. Medical and surgical options for long-term care. ( Marshall, JB, 1995) |
"Although Boerhaave syndrome is generally considered to have poor prognosis, conservative therapy may be effective in select cases with early detection of the perforation." | 1.33 | Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report. ( Katsuno, A; Makino, H; Matsuda, A; Matsutani, T; Miyashita, M; Nomura, T; Sasajima, K; Sasaki, J; Tajiri, T, 2006) |
"Forty of 78 patients dying of oesophageal cancer had the disease present at registration." | 1.32 | Mortality study of 18 000 patients treated with omeprazole. ( Bateman, DN; Colin-Jones, D; Hartz, S; Langman, M; Logan, RF; Mant, J; Murphy, M; Paterson, KR; Rowsell, R; Thomas, S; Vessey, M, 2003) |
"Such chronic ulcers have been associated with pain, stricture formation, and recurrent hemorrhage." | 1.28 | Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. ( Gimson, A; Polson, R; Westaby, D; Williams, R, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.89) | 18.7374 |
1990's | 21 (46.67) | 18.2507 |
2000's | 17 (37.78) | 29.6817 |
2010's | 3 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levy, AN | 1 |
Ali, N | 1 |
Andrici, J | 1 |
Hamilton, MJ | 1 |
Roux, C | 1 |
Briot, K | 1 |
Gossec, L | 1 |
Kolta, S | 1 |
Blenk, T | 1 |
Felsenberg, D | 1 |
Reid, DM | 1 |
Eastell, R | 1 |
Glüer, CC | 1 |
di Palmo, E | 1 |
Cazzato, S | 1 |
Tursini, S | 1 |
Salfi, NC | 1 |
Mazzotta, A | 1 |
Di Silverio Carulli, C | 1 |
Lima, M | 1 |
Bergamaschi, R | 1 |
Bernardi, F | 1 |
Cicognani, A | 1 |
Cakal, B | 1 |
Akbal, E | 1 |
Köklü, S | 1 |
Babalı, A | 1 |
Koçak, E | 1 |
Taş, A | 1 |
Bateman, DN | 1 |
Colin-Jones, D | 1 |
Hartz, S | 1 |
Langman, M | 1 |
Logan, RF | 1 |
Mant, J | 1 |
Murphy, M | 1 |
Paterson, KR | 1 |
Rowsell, R | 1 |
Thomas, S | 1 |
Vessey, M | 1 |
Hong, SP | 1 |
Park, PW | 1 |
Hwang, SG | 1 |
Ko, KH | 1 |
Kwak, SY | 1 |
Kim, SH | 1 |
Kwon, KS | 1 |
Shin, YW | 1 |
Ryu, JK | 1 |
Ryu, KH | 1 |
Park, SJ | 1 |
Won, WH | 1 |
Yoo, HM | 1 |
Bae, HM | 1 |
Park, MJ | 1 |
Woo, YK | 1 |
Kim, KC | 1 |
Kim, KH | 1 |
Na, SH | 1 |
Kim, JW | 1 |
Akbulut, S | 1 |
Yavuz, B | 1 |
Köseoğlu, T | 1 |
Gököz, A | 1 |
Saritaş, U | 1 |
Farinati, F | 1 |
Cardin, R | 1 |
Russo, VM | 1 |
Busatto, G | 1 |
Franco, M | 1 |
Falda, A | 1 |
Mescoli, C | 1 |
Rugge, M | 1 |
Sgouros, SN | 1 |
Vlachogiannakos, J | 1 |
Karamanolis, G | 1 |
Vassiliadis, K | 1 |
Stefanidis, G | 1 |
Bergele, C | 1 |
Papadopoulou, E | 1 |
Avgerinos, A | 1 |
Mantides, A | 1 |
Alonso Fernández, M | 1 |
Silvers, WS | 1 |
Levine, JS | 1 |
Poole, JA | 1 |
Naar, E | 1 |
Weber, RW | 1 |
Cooper, BT | 1 |
Chapman, W | 1 |
Neumann, CS | 1 |
Gearty, JC | 1 |
Lancaster, JL | 1 |
Gosh, S | 1 |
Sethi, R | 1 |
Tripathi, S | 1 |
Matsuda, A | 1 |
Miyashita, M | 1 |
Sasajima, K | 1 |
Nomura, T | 1 |
Makino, H | 1 |
Matsutani, T | 1 |
Katsuno, A | 1 |
Sasaki, J | 1 |
Tajiri, T | 1 |
Okuyama, K | 1 |
Saito, N | 1 |
Kume, E | 1 |
Noto, T | 1 |
Nagasaki, M | 1 |
Davies, M | 1 |
Wilton, LV | 1 |
Shakir, SA | 1 |
Konda, A | 1 |
Cappell, MS | 1 |
Dieterle, L | 1 |
Haines, DE | 1 |
Garg, PK | 1 |
Sidhu, SS | 1 |
Bhargava, DK | 1 |
Bataller, R | 1 |
Bordas, JM | 1 |
Ordi, J | 1 |
Llach, J | 1 |
Elizalde, JI | 1 |
Mondelo, F | 1 |
Jaspersen, D | 1 |
Körner, T | 1 |
Schorr, W | 1 |
Hammar, CH | 1 |
Marshall, JB | 1 |
Sood, A | 1 |
Sharma, M | 1 |
Jain, NP | 1 |
Chawla, LS | 1 |
Kumar, R | 1 |
Rakic, S | 1 |
Pesko, P | 1 |
Dunjic, M | 1 |
Gerzic, Z | 1 |
Przemioslo, RT | 1 |
Mee, AS | 1 |
Lesur, G | 1 |
Paupard, T | 1 |
Turner, L | 1 |
Bergemer, AM | 1 |
Parlier, H | 1 |
Dupuy, P | 1 |
Mosimann, F | 1 |
González Carro, P | 1 |
Toro, H | 1 |
Balanzó, J | 1 |
Vilardell, F | 1 |
Kobayashi, S | 1 |
Kawabe, N | 1 |
Miyata, F | 1 |
Ito, H | 1 |
Kazumiya, H | 1 |
Murase, K | 1 |
Kurokawa, S | 1 |
Fujishima, K | 1 |
Freston, JW | 1 |
Rose, PA | 1 |
Heller, CA | 1 |
Haber, M | 1 |
Jennings, D | 1 |
Borum, ML | 1 |
Marks, ZH | 1 |
Cuddihy, PJ | 1 |
Maheshwar, A | 1 |
Griffith, H | 1 |
Martín de Argila, C | 1 |
Boixeda de Miquel, D | 1 |
Moreira Vicente, V | 1 |
García Plaza, A | 1 |
de Mestier, P | 1 |
Achem, SR | 1 |
DeVault, KR | 1 |
Reichart, M | 1 |
Busch, OR | 1 |
Bruno, MJ | 1 |
Van Lanschot, JJ | 1 |
Miehsler, W | 1 |
Püspök, A | 1 |
Oberhuber, T | 1 |
Vogelsang, H | 1 |
Johlin, FC | 1 |
Labrecque, DR | 1 |
Neil, GA | 1 |
Fakir, M | 1 |
Saison, C | 1 |
Wong, T | 1 |
Matta, B | 1 |
Hardin, JM | 1 |
Larner, AJ | 1 |
Lendrum, R | 1 |
Camara, DS | 1 |
Corasanti, JG | 1 |
Gimson, A | 1 |
Polson, R | 1 |
Westaby, D | 1 |
Williams, R | 1 |
Bory, M | 1 |
Dupin, B | 1 |
Hendel, L | 1 |
Svejgaard, E | 1 |
Walsøe, I | 1 |
Kieffer, M | 1 |
Stenderup, A | 1 |
Hameeteman, W | 1 |
Tytgat, GN | 1 |
Lee, FI | 1 |
Isaacs, PE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 2: Treatment Study[NCT00462241] | 115 participants (Actual) | Interventional | 2006-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
7 reviews available for omeprazole and Esophageal Diseases
Article | Year |
---|---|
A rare association of inlet patch with laryngospasm: a report of two children and literature review.
Topics: Alginates; Anti-Ulcer Agents; Child; Child, Preschool; Esophageal Diseases; Female; Gastric Mucosa; | 2011 |
Severe gastroesophageal reflux disease. Medical and surgical options for long-term care.
Topics: Antacids; Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophageal Diseases; Esophagogast | 1995 |
Safety profile of Lansoprazole: the US clinical trial experience.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clinical Trials as Topic; Esophageal Dis | 1999 |
Esophageal stricture from idiopathic ulcers in an AIDS patient: a case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Ulcer Agents; Biopsy; Endoscopy, Digestive System; E | 1999 |
[Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Topics: Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Esophageal Diseases; Esophagitis; Gastritis; | 1999 |
Recent developments in chest pain of undetermined origin.
Topics: Angina Pectoris; Anti-Ulcer Agents; Chest Pain; Diagnosis, Differential; Esophageal Diseases; Humans | 2000 |
Update: gastroenterology and hepatology.
Topics: Chronic Disease; Esophageal Diseases; Gastrointestinal Diseases; Humans; Interferons; Liver Diseases | 1991 |
5 trials available for omeprazole and Esophageal Diseases
Article | Year |
---|---|
Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum.
Topics: Anti-Ulcer Agents; DNA Adducts; DNA Damage; Esophageal Diseases; Esophagogastric Junction; Female; G | 2004 |
Long-term acid suppressive therapy may prevent the relapse of lower esophageal (Schatzki's) rings: a prospective, randomized, placebo-controlled study.
Topics: Anti-Ulcer Agents; Dilatation; Esophageal Diseases; Female; Gastroesophageal Reflux; Humans; Hydroge | 2005 |
Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications. Double-blind randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Esophageal and Gastric Varices; Eso | 1995 |
Omeprazole in the management of sclerotherapy-induced esophageal ulcers resistant to H2 blocker treatment.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance; Esophageal and Gastric Varices; Esophageal Diseases | 1995 |
33 other studies available for omeprazole and Esophageal Diseases
Article | Year |
---|---|
It's What's Up Front That Counts-Part Two: Esophageal Crohn's Disease Complicated by Recurrent Upper Gastrointestinal Bleeding.
Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Colonoscopy; Colostomy; Con | 2019 |
Increase in vertebral fracture risk in postmenopausal women using omeprazole.
Topics: Aged; Anti-Ulcer Agents; Esophageal Diseases; Europe; Female; Humans; Menopause; Middle Aged; Omepra | 2009 |
Acute therapy with intravenous omeprazole on caustic esophageal injury: a prospective case series.
Topics: Adult; Burns, Chemical; Caustics; Cohort Studies; Emergency Treatment; Esophageal Diseases; Esophago | 2013 |
Mortality study of 18 000 patients treated with omeprazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cause of Death; Child; Duodenal Disea | 2003 |
Crohn's disease with isolated esophagus and gastric involvement.
Topics: Adult; Anti-Ulcer Agents; Azathioprine; Biopsy; Crohn Disease; Endoscopy, Gastrointestinal; Esophage | 2004 |
[Oesophageal ulcer and doxycycline].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Doxycycline; Drug Therapy, Combination; Esophageal Disease | 2005 |
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Androstadienes; Anti-Allergic Agents; Cough; Endoscopy, Gas | 2006 |
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Eso | 2006 |
Can heterotopic gastric mucosa present as globus pharyngeus?
Topics: Anti-Ulcer Agents; Choristoma; Conversion Disorder; Diagnosis, Differential; Esophageal Diseases; Fe | 2006 |
Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report.
Topics: Adult; Anti-Bacterial Agents; Chest Pain; Combined Modality Therapy; Endoscopy, Gastrointestinal; En | 2006 |
Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Topics: Abietanes; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therap | 2007 |
Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England.
Topics: Adverse Drug Reaction Reporting Systems; Cohort Studies; Diarrhea; Drug Monitoring; Dyspepsia; Engla | 2008 |
Esophageal ulceration from high-intensity focused US catheter ablation for pulmonary vein isolation: a novel complication in the treatment of symptomatic refractory atrial fibrillation.
Topics: Atrial Fibrillation; Catheter Ablation; Drug Therapy, Combination; Esophageal Diseases; Esophagoscop | 2008 |
Upper gastrointestinal bleeding: a complication of "inlet patch mucosa" in the upper esophagus.
Topics: Adult; Biopsy, Needle; Endoscopy, Digestive System; Esophageal Diseases; Gastric Mucosa; Gastrointes | 1995 |
Esophageal candidiasis following omeprazole therapy: a report of two cases.
Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto | 1995 |
Acid-suppression did not enhance healing of gastric ulcer associated with paraesophageal hernia after hernial reduction.
Topics: Esophageal Diseases; Gastric Acid; Hernia; Herniorrhaphy; Humans; Male; Middle Aged; Omeprazole; Ran | 1995 |
Omeprazole in possible esophageal Crohn's disease.
Topics: Adolescent; Crohn Disease; Esophageal Diseases; Humans; Male; Omeprazole | 1994 |
[Esophageal mycosis during treatment with omeprazole].
Topics: Esophageal Diseases; Fluconazole; Humans; Male; Middle Aged; Mycoses; Omeprazole; Stomach Ulcer | 1993 |
Esophageal candidiasis, omeprazole therapy, and organ transplantation--a word of caution.
Topics: Candidiasis; Esophageal Diseases; Humans; Liver Transplantation; Omeprazole; Opportunistic Infection | 1993 |
[Esophageal candidiasis during omeprazole treatment].
Topics: Aged; Aged, 80 and over; Candidiasis; Esophageal Diseases; Humans; Male; Omeprazole; Peptic Ulcer He | 1993 |
[A case of Behcet's syndrome associated with esophageal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Behcet | 1998 |
Symptomatic heterotopic gastric mucosa in the upper oesophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Choristoma; Cimetidine; Esophageal Disea | 1998 |
[Congress of the American College of Surgeons (ACS). San Francisco, 10-15 October 1999].
Topics: Anti-Ulcer Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholang | 1999 |
Black esophagus: a view in the dark.
Topics: Acute Disease; Aged; Anti-Ulcer Agents; Esophageal Diseases; Esophagus; Gastric Outlet Obstruction; | 2000 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |
Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy.
Topics: Adult; Aged; Endoscopy; Esophageal and Gastric Varices; Esophageal Diseases; Female; Humans; Male; M | 1992 |
Septicemia due to Yersinia enterocolitica in a hemodialyzed, iron-depleted patient receiving omeprazole and oral iron supplementation.
Topics: Aged; Anemia, Hypochromic; Bacteremia; Esophageal Diseases; Female; Ferrous Compounds; Humans; Omepr | 1992 |
Oesophageal candidiasis after omeprazole therapy.
Topics: Aged; Candidiasis; Esophageal Diseases; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Stomach | 1992 |
Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Diseases; Follow-Up Studies; Humans; Injections; Middle A | 1990 |
[Angina-like chest pain of esophageal origin].
Topics: Catheterization; Chest Pain; Esophageal Diseases; Humans; Hydrochloric Acid; Hydrogen-Ion Concentrat | 1989 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole | 1988 |
Healing of chronic Barrett ulcers with omeprazole.
Topics: Aged; Anti-Ulcer Agents; Barrett Esophagus; Benzimidazoles; Drug Resistance; Esophageal Diseases; Es | 1986 |
Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
Topics: Barrett Esophagus; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Diseases; Eso | 1988 |